4//SEC Filing
CELGENE CORP /DE/ 4
Accession 0001104659-20-081337
CIK 0001280600operating
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 5:24 PM ET
Size
7.0 KB
Accession
0001104659-20-081337
Insider Transaction Report
Form 4
CELGENE CORP /DE/
10% Owner
Transactions
- Purchase
Common Stock
2020-07-01$92.50/sh+108,108$9,999,990→ 6,971,772 total
BRISTOL MYERS SQUIBB CO
10% Owner
Transactions
- Purchase
Common Stock
2020-07-01$92.50/sh+108,108$9,999,990→ 6,971,772 total
Footnotes (2)
- [F1]This statement is being filed jointly by Celgene Corporation and Bristol-Myers Squibb Company.
- [F2]These shares are owned directly by Celgene Corporation, which is a wholly owned subsidiary of Bristol-Myers Squibb Company. Bristol-Myers Squibb Company is an indirect beneficial owner of the reported securities.
Documents
Issuer
ACCELERON PHARMA INC
CIK 0001280600
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000816284
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 5:24 PM ET
- Size
- 7.0 KB